Mergers & Acquisitions ·
CDT partners with Manoira to evaluate clinical assets for animal health products
CDTCDT Equity Inc.
CDT Equity Inc. entered into an evaluation agreement with Manoira Corporation to analyze its clinical-stage compounds AZD1656 and AZD5904 to determine if they can enhance Manoira's upcoming animal healthcare product range, scheduled for launch in the first quarter of 2027. CDT issued 1,347,616 shares valued at $195,000 to settle the payment. The agreement allows Manoira to test these assets and, if successful, pursue licensing discussions. Additionally, the company issued shares for consulting services, a securities purchase agreement settlement, and executive severance. CDT Equity Inc. is a data-driven biopharmaceutical development company focused on identifying and advancing therapeutic assets through scientific innovation.